藥品費(fèi)用占患者總醫(yī)療費(fèi)用的比例可以反映醫(yī)療衛(wèi)生資源消耗的內(nèi)在結(jié)構(gòu)，常作為醫(yī)院藥品費(fèi)用控制的評(píng)價(jià)指標(biāo)，控制藥品費(fèi)用占比可以優(yōu)化用藥結(jié)構(gòu)，促進(jìn)醫(yī)藥費(fèi)用合理發(fā)展，但藥品費(fèi)用占比評(píng)價(jià)指標(biāo)也有其內(nèi)在的局限性，需要積極探索結(jié)構(gòu)優(yōu)化的方法，以促進(jìn)我國(guó)醫(yī)藥衛(wèi)生事業(yè)的健康發(fā)展。

The proportion of drug cost in total medicinal expenses could reflect the inner structure of health resource consumption and be often taken as a hospital evaluation index of drug cost control. To control the proportion of drug cost could optimize the drug structure, promote the reasonable development of drug cost, but the drug cost also has its own limitations. We need to actively explore the optimization of medical expenses structure in order to promote the development of pharmaceutical and health care.